Metastatic cutaneous apocrine adenocarcinoma successfully treated with systemic anti‐androgen therapy—A case report

Metastatic cutaneous apocrine adenocarcinoma successfully treated with systemic anti‐androgen therapy—A case report

Abstract Primary cutaneous apocrine adenocarcinoma (PCAC) is an extremely rare neoplasm involving the sweat glands. Due to a lack of cases, there is no consensus for the systemic treatment of locally advanced or metastatic PCAC. Anti‐androgen therapy may have activity in inoperable or metastatic PCA...

Full description

Bibliographic Details
Main Authors: Fanny Collette, Marc Hamoir, Pascal Van Eeckhout, Philippe D’Abadie, Thierry Duprez, Sandra Schmitz, Jean‐Pascal Machiels
Format: Article
Language:English
Published: Wiley 2020-12-01
Series:Clinical Case Reports
Subjects:
androgen receptor
anti‐androgen therapy
metastatic cancer
Primary cutaneous apocrine adenocarcinoma
sweat glands
Online Access:https://doi.org/10.1002/ccr3.3434

Internet

https://doi.org/10.1002/ccr3.3434

Similar Items